OrthoPediatrics expanded its agent network marketing pediatric orthopedic devices in Germany, Austria and Switzerland as part of its previously communicated strategy.
The company converted long-standing distributor partners to sales agencies in these regions. Under the agency model, they will continue to benefit from commercial relationships established by stocking distributors while directly consigning instrument and implant sets to hospitals. This relieves the former distributors from significant capital investment requirements and removes a significant bottleneck to growth in those markets.
This increases from eight to 11 the number of countries where OrthoPediatrics has implemented the agency model as part of its pursuit of international expansion. During 2020, agencies were the most important revenue growth contributor for international sales.
David Bailey, President, said, “We also plan to broaden our product portfolio in these markets to include new technologies such as Orthex and ApiFix to expand our ability to improve the lives of children in the region."